Riskpilot← Back to searchSign inGet full accessJDW Medical AB
ABActiveOrg 5592244411Sjötorgsgatan 4Hospital activities · NACE 8610Est. 20191 employees
Revenue 2024
SEK 614K
+19% vs 2023
EBITDA margin
17.0%
-72% vs 2023
Equity ratio
90.7%
Financial strength
Net profit 2024
SEK 83K
-71% vs 2023
| Revenue | SEK 614K | +19% |
| EBITDA | SEK 104K | -72% |
| Net profit | SEK 83K | -71% |
| Total assets | SEK 437K | -7% |
| Equity | SEK 397K | +26% |
| Employees | 1 | — |
Legal name
JDW Medical AB
Org number
5592244411
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
29 oktober 2019
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets ändamål är att bedriva tjänster och konsultation inom hälso- och sjukvård, ekonomisk förvaltning samt därmed förenlig verksamhet.
Address
Sjötorgsgatan 4
Email
daniel.wallgren@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 | 21 | 6 | 518 | 614 |
| Staff expenses | — | — | −0 | −22 | −359 |
| EBITDA | −68 | −12 | 0 | 367 | 104 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −68 | −12 | 0 | 367 | 104 |
| Net financials | — | — | 80 | −0 | 0 |
| Profit before tax | −68 | −12 | 80 | 367 | 105 |
| Tax | −0 | −0 | −1 | −77 | −22 |
| Net profit | −68 | −12 | 79 | 289 | 83 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 64 | 59 | 50 | 471 | 437 |
| Equity | −18 | −30 | 25 | 315 | 397 |
| Long-term debt | 80 | 84 | 24 | 24 | 0 |
| Short-term debt | 2 | 5 | 1 | 132 | 40 |
| Total debt | 82 | 89 | 25 | 156 | 40 |
EBITDA margin
17.0%
This company
15.8%
Market median
+8% vs market
20202024
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
13.5%
This company
8.1%
Market median
+67% vs market
20202024
Asset turnover
1.40×
This company
1.12×
Market median
+25% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
ES Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JDW Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Sophie Wallgren | Chief Executive Officer | 0 companies |
| Ulla Viviann Larsson | Deputy Board Member | 0 companies |
| Jan Daniel Wallgren | Board of Directors | 0 companies |
| Thomas Erik Bergman | Deputy Board Member | 0 companies |